Validation of the French Version of the Score on Quality of Life (HiSQOL) in Hidradenitis Suppurativa (QUALIVER)
NCT05986825 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2024-07-23
Summary
Validation of the French Version of the Score on Quality of Life in Hidradenitis Suppurativa. The French HiSQOL will be completed by 60 patients with hidradenitis suppurativa a first time, and a second time 1 week later.
Conditions
Interventions
- OTHER
-
Verneuil questionnaire Validation
Request patient to Complete the questionnaire for validation of the French version
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-29
- Primary Completion
- 2023-12-22
- Completion
- 2023-12-22
Countries
- France
Study Locations
More Related Trials
-
Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa
NCT07244510 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing
NCT02163746 ·Status: COMPLETED ·Phase: NA
-
Gentian Violet Treatment for Hidradenitis Suppurativa
NCT04388163 ·Status: WITHDRAWN ·Phase: PHASE2
-
Perforator Flaps for Axillary Hidradenitis Suppurativa
NCT03784313 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa
NCT06361836 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
NCT06058520 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.
NCT05921994 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy
NCT05139602 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
NCT07170917 ·Status: RECRUITING ·Phase: PHASE2
-
Managed Access Programs for AIN457, Secukinumab
NCT05583604 ·Status: AVAILABLE
-
Real-world Secukinumab Outcomes in Canadian HS Patients
NCT07282015 ·Status: RECRUITING
-
A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial
NCT04876391 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa
NCT06932003 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Patient Satisfaction in Cutaneous Surgery
NCT01535963 ·Status: ACTIVE_NOT_RECRUITING
-
Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation
NCT06517732 ·Status: ACTIVE_NOT_RECRUITING
-
Intralesional Acyclovir Versus Cryotherapy in the Treatment of Plantar Warts. A Randomized Controlled Trial.
NCT06261684 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Development of Dermatology-related Quality of Life Assessment in Patients Treated With Epidermal Growth Factor Receptor (EGFR) Inhibitors
NCT01015326 ·Status: COMPLETED
-
Evaluation of the Efficacy of Cryotherapy Combined With Intralesional Hepatitis B Virus Vaccine Versus Either Therapy in the Treatment of Multiple Cutaneous Warts :a Comparative Study
NCT05902624 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Evaluation of Combined Treatment With Er:YAG & Nd:YAG Lasers for the Treatment of Recalcitrant Warts
NCT05768893 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic Response
NCT03296397 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Hidradenitis Suppurativa
NCT04856930 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Squamous Cell Carcinoma antigen2 in Verruca Vulgaris
NCT05409365 ·Status: UNKNOWN
-
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
NCT07244263 ·Status: RECRUITING ·Phase: PHASE2
-
Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa
NCT07109765 ·Status: RECRUITING
-
Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population
NCT01598779 ·Status: COMPLETED